Karmanos Cancer Institute Multi Disciplinary Team Leader, Hematologic Malignancies Program search profile available for review
The Barbara Ann Karmanos Cancer Institute (KCI) is a unique, urban-based integrated center of research, patient care, and education located in mid-town Detroit dedicated to the prevention, early detection, treatment, and eventual eradication of cancer. KCI is affiliated with Wayne State University (WSU). KCI has been a National Cancer Institute (NCI) - designated Comprehensive Cancer Center since 1978 and operates the only hospital in Michigan dedicated exclusively to fighting cancer. The main campus of KCI and its cancer hospital are located near major hospital networks and the WSU School of Medicine, and near major art, cultural and sports venues in the vibrant midtown area of Detroit. Since January 2014, KCI expanded its delivery of cancer care through the partnership with McLaren Health Care.
The KCI has one of the largest and best clinical trial programs in the United States. Through the commitment of 1,800 staff, including over 300 physicians and researchers and supported by thousands of volunteer and financial donors, KCI cares for approximately 12,000 new patients annually and conducts more than 400 cancer-specific clinical trials. KCI strives to prevent, detect and eradicate cancer. The long-term partnership of KCI and the WSU of Medicine enhances the collaboration between critical research and academics related to cancer care.
The Opportunity – Multi Disciplinary Team Leader – Hematologic Malignancies (MDT)
KCI seeks to attract a dynamic leader to build upon the historical successes of the MDT program to partner with leadership of the cancer institute and drive continued outstanding research exploration, discovery, trials and delivery of care. KCI offers an outstanding research environment, and will commit to significant startup funding and recurring support, along with a competitive salary and fringe benefit package to attract the strongest candidate.
KCI/WSU seeks a physician or physician-scientist at the senior level to head the Multidisciplinary Team (MDT) for Hematologic Malignancies at the Barbara Ann Karmanos Cancer Center. The applicant will be expected to take an active role in clinical translational research in hematologic malignancies and faculty development. The MDT consists of 7-full time faculty who concentrate on hematologic malignancies. The MDT currently operates from the new outpatient Dresner Clinic which houses both the hematologic malignancy and BMT programs. The outpatient clinic is connected to the free standing Karmanos Cancer Hospital where all the inpatient activity occurs. The center is part of a growing 12 hospital system with facilities throughout the state and is a tertiary referral center. The position comes with the substantial philanthropic support from the Dresner Foundation to be used for research, recruitment of new faculty, and patient support services. Applicants should have a proven record of success in developing clinical translational research and mentorship in the areas of hematologic malignancies.
The Joseph Dresner Family Clinic for Hematologic Malignancies & Stem Cell Transplantation
The Joseph Dresner Family Clinic for Hematologic Malignancies & Stem Cell Transplantation enables efficient and coordinated care for patients seen by both the Malignant Hematology and Stem Cell and Bone Marrow Transplant multidisciplinary teams.
Patients with multiple myeloma, amyloidosis, leukemia, lymphoma and similar cancers have efficient, one-stop access to Karmanos experts who specialize in treating those diseases. All doctors involved are able to see patients simultaneously, as well as create and implement joint treatment plans.
The Clinic will also allow Karmanos to expand its future cancer research and clinical trials focusing on leukemia, multiple myeloma, lymphoma and myelodysplastic syndrome (MDS). The center is located at Karmanos’ midtown campus in Detroit. The Dresner Clinic is made possible by a generous $5 million gift by the late Joseph Dresner, who was diagnosed with MDS in 2002.
KCI offers 13 multidisciplinary teams; each designed and staffed specifically to ensure that patients and their families get their cancer diagnosis and treatment right the first time. Each team consists of cancer specialists who are focused on your particular cancer and who have devoted their careers to fighting the very cancer with which you are confronted.
The KCI team members include specialists from each discipline including, diagnostic, medical and surgical oncology, radiation oncology; pathology; radiology; oncology nursing; supportive care; and, when appropriate, genetics.
Karmanos’ Bone Marrow & Stem Cell Transplant Specialists
KCI’s Bone Marrow & Stem Cell Transplant Multidisciplinary Team includes specialists in medical hematology and oncology, infectious disease, immunotherapy, pediatrics and internal medicine who bring years of experience to the field of transplantation. The team is actively involved in clinical research in bone marrow and peripheral blood stem cells transplants.
Karmanos’ Malignant Hematology Specialists
The KCI Malignant Hematology Multidisciplinary Team includes hematologists, medical oncologists, radiation oncologists, pathologists, cytogeneticists, pharmacists, specialized nurse practitioners, dietitians, and social workers. The team is entirely focused on treating hematologic malignancies and shares its collective expertise to create a customized treatment plan for each patient.
Cancer and conditions treated include:
• Non-Hodgkin's Lymphoma
• Hodgkin's Lymphoma
• Multiple Myeloma
• Myelodysplasia (MDS)
• Aplastic Anemia
• PhD, MD, or MD/PhD degree or equivalent; academic accomplishments commensurate with appointment at the rank of Associate or Full Professor;
• Strong evidence of clinical productivity relevant to the major themes of the MDT Program.
• Demonstrated track record of proven leadership in relation to program development;
• Ability to create and promote program projects, and other collaboration among program members and research KCI programs;
• A strategic national academic and research/clinical leader, grounded in personal integrity with the ability to energize, inspire, and encourage faculty innovation as well as interdisciplinary collaboration;
• Demonstrated ability to manage a complex academic organization and work effectively with colleagues across divisions;
• Demonstrated success as an administrator and fiscal manager;
• Demonstrated ability to motivate key constituencies, lead the development of mutually beneficial relationships with partners, and recruit, retain, mentor, and develop superb academic faculty and co-leaders;
• Ability to foster and promote gender equity and ethnic diversity among faculty and staff to enrich the university, further its research mission, and preserve the uniqueness of KCI.